|
Volumn 27, Issue 1, 2001, Pages 10-18
|
Metabolic evaluation of stone disease
|
Author keywords
Calculi; Metabolic disease; Risk factors; Stone; Urolithiasis
|
Indexed keywords
ALLOPURINOL;
AMMONIA;
BACTERIAL ENZYME;
CALCIUM OXALATE;
CALCIUM PHOSPHATE;
CELLULOSE PHOSPHATE;
CITRATE CALCIUM;
CITRATE POTASSIUM;
CITRIC ACID;
CYSTEINE;
CYSTINE;
HYDROCHLOROTHIAZIDE;
PARATHYROID HORMONE;
PENICILLAMINE;
PHOSPHATE;
POTASSIUM BICARBONATE;
PROTEIN;
PURINE;
PYRIDOXINE;
SODIUM;
STRUVITE;
THIAZIDE DIURETIC AGENT;
TIOPRONIN;
UREASE;
UREASE INHIBITOR;
URIC ACID;
XANTHINE;
ARTICLE;
CALCIUM BALANCE;
CALCIUM STONE;
CAUCASIAN;
CONTROLLED STUDY;
CRYSTALLIZATION;
CYSTINURIA;
DEEP VEIN THROMBOSIS;
DERMATITIS;
DIALYSIS;
DRUG INDICATION;
DRUG MECHANISM;
FEMALE;
FLUID INTAKE;
GASTROINTESTINAL SYMPTOM;
GENDER;
GOUT;
HUMAN;
HYPERCALCIURIA;
HYPEROXALURIA;
HYPERURICOSURIA;
HYPOKALEMIA;
MALE;
METABOLIC DISORDER;
NEGRO;
PANCYTOPENIA;
PATHOPHYSIOLOGY;
PROTEIN INTAKE;
PURINE METABOLISM;
RACE DIFFERENCE;
RECURRENT DISEASE;
RISK;
SIDE EFFECT;
SODIUM INTAKE;
URIC ACID STONE;
URINARY TRACT INFECTION;
URINE PH;
URINE VOLUME;
UROLITHIASIS;
|
EID: 0035070876
PISSN: 15176878
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (31)
|